SCHEMBL28296511

SCHEMBL28296511

O=C(c1cc2cc(O)ccc2o1)N1CCOCC1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.73
FLT3 P36888 1/20 0.58
ALDH1A1 P00352 6/20 0.57
NPC1 O15118 3/20 0.57
LMNA P02545 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
MAPT P10636 2/20 0.56
KDM4E B2RXH2 3/20 0.55
HPGD P15428 2/20 0.55
GAA P10253 2/20 0.55
HSD17B10 Q99714 2/20 0.55
GLA P06280 1/20 0.55
CASP1 P29466 1/20 0.55
BRCA1 P38398 1/20 0.55
CASP7 P55210 1/20 0.55
POLB P06746 3/20 0.54
HRH4 Q9H3N8 2/20 0.53
CLK1 P49759 1/20 0.52
DYRK1A Q13627 1/20 0.52
DYRK1B Q9Y463 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14320823 0.86 RAB9A (0.73) RAB9AFLT3ALDH1A1NPC1LMNA
SCHEMBL28294795 0.84 HRH4 (0.74) RAB9AFLT3ALDH1A1NPC1LMNA
SCHEMBL18931494 0.84 RAB9A (0.71) RAB9AALDH1A1NPC1LMNASMN1; SMN2
SCHEMBL18889274 0.84 RAB9A (1.00) RAB9AALDH1A1NPC1LMNASMN1; SMN2
SCHEMBL18889298 0.82 MAPT (0.78) RAB9AALDH1A1NPC1LMNASMN1; SMN2
SCHEMBL18889224 0.81 RAB9A (0.67) RAB9AALDH1A1NPC1LMNASMN1; SMN2
SCHEMBL7159351 0.78 RAB9A (0.56) RAB9AFLT3ALDH1A1NPC1LMNA
SCHEMBL7199038 0.77 ALDH1A1 (0.51) RAB9AFLT3ALDH1A1NPC1LMNA
SCHEMBL3644986 0.77 ALDH1A1 (0.55) RAB9AFLT3ALDH1A1NPC1LMNA
SCHEMBL3644984 0.77 ALDH1A1 (0.55) RAB9AFLT3ALDH1A1NPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110172051-A IRE-1 alpha inhibitor 复星弘创(苏州)医药科技有限公司 2019-08-27 CN disclosed
CN-107082770-B IRE-1 alpha inhibitor 复星弘创(苏州)医药科技有限公司 2019-04-23 CN disclosed